NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,835 | -9.6% | 1,194 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $58,441 | -34.4% | 1,201 | -25.2% | 0.00% | -50.0% |
| Q1 2023 | $89,110 | +39.7% | 1,605 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $63,790 | -30.7% | 1,588 | -24.2% | 0.00% | -33.3% |
| Q3 2022 | $92,000 | +39.4% | 2,094 | +12.9% | 0.00% | +50.0% |
| Q2 2022 | $66,000 | +247.4% | 1,854 | +303.0% | 0.00% | +100.0% |
| Q1 2022 | $19,000 | +137.5% | 460 | +454.2% | 0.00% | – |
| Q4 2021 | $8,000 | -33.3% | 83 | -23.9% | 0.00% | – |
| Q3 2021 | $12,000 | +33.3% | 109 | +45.3% | 0.00% | – |
| Q2 2021 | $9,000 | +80.0% | 75 | +63.0% | 0.00% | – |
| Q1 2021 | $5,000 | +400.0% | 46 | +253.8% | 0.00% | – |
| Q4 2020 | $1,000 | – | 13 | +550.0% | 0.00% | – |
| Q3 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |